XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (279,239) $ (249,563) $ (53,225)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 51,878 45,922 40,064
Stock-based compensation 298,992 259,159 105
Gain on extinguishment of debt   (10,000)  
Deferred income taxes (2,668) (2,475) (98)
Change in fair value of warrants and derivative liabilities 410 5,000 28,100
Change in the fair value of acquisition related liabilities 12,990 (1,823) 299
Others, net (592) 1,868 3,881
Change in non-cash working capital (net of acquisitions):      
Accounts receivable (19,826) (1,155) 24,347
Prepaid expenses (270) (3,067) (551)
Other current assets (214) 5,725 632
Other non-current assets 63 (592) 1,479
Deferred revenue (4,566) 2,813 2,402
Accounts payable 13,530 (22,243) 4,443
Accrued expenses and other current liabilities 10,001 14,618 (15,491)
Other non-current liabilities (2,003) 105 (848)
Net cash provided by operating activities 78,486 44,292 35,539
Cash flows from investing activities:      
Capital expenditures (22,232) (9,482) (2,249)
Website and software development costs (17,004) (17,274) (22,958)
Business and asset acquisitions, net of cash acquired (9,209) (20,093)  
Net cash used for investing activities (48,445) (46,849) (25,207)
Cash flows from financing activities:      
Cash paid for acquisition-related liabilities (5,959) (9,850) (717)
Proceeds from pay-check protection program loan     10,000
Proceeds from credit facilities, net of issuance cost 5,625 183,311  
Proceeds from initial public offering, net of issuance costs   126,538  
Repurchase of shares (9,607) (64,468)  
Proceeds from employees' stock purchase plan 2,742 809  
Exercise of warrants and options 199 137  
Repayments against the credit facilities (5,625) (180,745) (6,500)
Net cash (used for) / provided by financing activities (12,625) 55,732 2,783
Effect of exchange rate changes on cash and cash equivalents (165) (41) (208)
Net increase in cash and cash equivalents, including restricted cash 17,251 53,134 12,907
Cash and cash equivalents and restricted cash, beginning of period 103,859 50,725 37,818
Cash and cash equivalents and restricted cash, end of period 121,110 103,859 50,725
Supplemental cash flow disclosures including non-cash activities:      
Cash paid for interest, net 5,673 7,004 13,070
Cash paid for income taxes, net 1,611 1,758 1,296
Liability established in connection with acquisitions 20,529 10,185  
Capitalized stock-based compensation as website and software development costs 5,394 10,196  
Shares issued in connection with acquisitions and other agreements 19,005 29,650 424
Dividends on redeemable convertible preferred stock settled in Company's equity   60,082  
Non-cash settlement of warrants and derivative liabilities 410 63,100  
Right-to-use asset established 9,559    
Operating lease liabilities established 12,050    
Non-cash consideration for website and software development costs $ 1,654 $ 1,551 $ 1,110